Astrana Health, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US03763A2078
USD
22.79
-0.03 (-0.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Astrana Health, Inc. stock-summary
stock-summary
Astrana Health, Inc.
Miscellaneous
Apollo Medical Holdings, Inc. is a physician-centric integrated population health management company working to provide coordinated, outcomes-based medical care. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. Its physician network consists of primary care physicians, specialist physicians and hospitalists. The Company has other integrated and synergistic operations, including management service organizations (MSOs) that provide management and other services to its affiliated IPAs; outpatient clinics and hospitalists that coordinate the care of patients in hospitals. The Company operate primarily through its subsidiaries: Network Medical Management (NMM), Apollo Medical Management, Inc. (AMM), APAACO and Apollo Care Connect, Inc. (Apollo Care Connect).
Company Coordinates stock-summary
Company Details
1668 S Garfield Ave Fl 2nd , ALHAMBRA CA : 91801-5474
stock-summary
Tel: 1 626 2820288
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 51 Schemes (34.76%)

Foreign Institutions

Held by 87 Foreign Institutions (4.85%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Kenneth Sim
Chairman of the Board, Co-Chief Executive Officer, Executive Director
Dr. Thomas Lam
President, Co-Chief Executive Officer, Director
Mr. Mitchell Kitayama
Lead Independent Director
Ms. Linda Marsh
Director
Mr. Matthew Mazdyasni
Director
Dr. Ernest Bates
Independent Director
Mr. John Chiang
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
655 Million
(Quarterly Results - Jun 2025)
Net Profit:
10 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 1,654 Million (Small Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.10

stock-summary
Return on Equity

3.62%

stock-summary
Price to Book

2.16